Testicular cancer seen as "stalking horse" for other cancers.
Vastag
B
B
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism*; D006063:Chorionic Gonadotropin / Q000097:blood; D002881:Chromosomes, Human, Pair 12; D002945:Cisplatin / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm; D005047:Etoposide / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D009369:Neoplasms / Q000175:diagnosis* / Q000188:drug therapy* / Q000378:metabolism; D013736:Testicular Neoplasms / Q000175:diagnosis* / Q000188:drug therapy* / Q000378:metabolism; D000509:alpha-Fetoproteins / Q000378:metabolism
D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D000972:Antineoplastic Agents, Phytogenic; D014408:Biomarkers, Tumor; D006063:Chorionic Gonadotropin; D000509:alpha-Fetoproteins; D005047:Etoposide; D003520:Cyclophosphamide; D007770:L-Lactate Dehydrogenase; D002945:Cisplatin